ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 52 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,813 | -62.2% | 9,890 | -68.4% | 0.00% | – |
| Q1 2023 | $68,254 | -86.8% | 31,309 | -26.9% | 0.00% | -100.0% |
| Q4 2022 | $515,257 | +175.5% | 42,831 | +48.7% | 0.00% | +200.0% |
| Q3 2022 | $187,000 | -23.0% | 28,795 | -45.8% | 0.00% | -50.0% |
| Q2 2022 | $243,000 | -50.1% | 53,128 | -5.7% | 0.00% | -50.0% |
| Q1 2022 | $487,000 | -47.4% | 56,348 | -13.0% | 0.00% | -42.9% |
| Q4 2021 | $925,000 | +320.5% | 64,799 | +294.9% | 0.01% | +133.3% |
| Q2 2021 | $220,000 | -4.3% | 16,407 | -69.8% | 0.00% | 0.0% |
| Q4 2020 | $230,000 | +16.8% | 54,291 | -28.0% | 0.00% | 0.0% |
| Q3 2020 | $197,000 | +245.6% | 75,395 | +365.7% | 0.00% | +200.0% |
| Q2 2020 | $57,000 | – | 16,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 781,292 | $2,039,172 | 1.87% |
| GSA CAPITAL PARTNERS LLP | 88,923 | $232 | 0.02% |
| Glass Jacobson Investment Advisors llc | 12,255 | $31,986 | 0.02% |
| Rathbones Group PLC | 289,803 | $756,386 | 0.01% |
| N.E.W. Advisory Services LLC | 12,960 | $33,826 | 0.01% |
| Virtu Financial LLC | 17,388 | $45 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $14,687 | 0.00% |
| ALGERT GLOBAL LLC | 14,680 | $38 | 0.00% |
| Close Asset Management Ltd | 11,400 | $30 | 0.00% |
| Altshuler Shaham Ltd | 12,847 | $33,408 | 0.00% |